Fig. 3.
Overall survival of 41 patients who had both pre- and post-ASHAP gallium. According to gallium response, 23 became gallium negative (19 clinical CR + 4 clinical PR) whereas 18 remained gallium positive (16 clinical PR + 2 minor responses).
Overall survival of 41 patients who had both pre- and post-ASHAP gallium. According to gallium response, 23 became gallium negative (19 clinical CR + 4 clinical PR) whereas 18 remained gallium positive (16 clinical PR + 2 minor responses).
